CIG could not only treat early AD but also possess beneficial effects on moderate to severe AD.
CIG has the potential effect to ameliorate the daily living qualities and the lifespan of AD patients.
The pharmacological mechanism of CIG related to anti-hyperphosphorylation of tau in SAMP8 mice, which benefits to AD treatment.